ArticleHuman brain mapping2025
Unraveling Hierarchical Brain Dysfunction in Major Depressive Disorder: A Multimodal Imaging and Transcriptomic Approach.
Article in Human brain mapping, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Alterations in brain structure-function coupling associated with musical training.Frontiers in human neuroscience · 2026Article
- Structural, functional and neurochemical imaging mapping of non-motor symptoms in Parkinson's disease.Brain communications · 2026Article
- Unraveling Hierarchical Brain Dysfunction in Major Depressive Disorder: A Multimodal Imaging and Transcriptomic Approach.Human brain mapping · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Major depressive disorder (MDD) is characterized by deficits in sensory processing and higher-order executive functions, reflecting dysfunction in the hierarchical organization of the brain. However, current methods for investigating brain hierarchy in MDD have not fully integrated multimodal data, and the underlying biological mechanisms remain poorly understood. We acquired diffusion tensor imaging and functional magnetic resonance imaging (fMRI) data from 100 participants with MDD and 77 healthy controls (HCs). The structural-decoupling index (SDI) was employed to quantify the hierarchical organization in MDD and HC. We identified intergroup differences in the hierarchical brain organization and explored the molecular mechanism related to significantly different brain regions by investigating genetic factors and their relationship with neurotransmitter receptors/transporters. Finally, 10-fold cross-validation was used to develop a support vector machine (SVM) classification model. Dysfunctional hierarchical organization in MDD was characterized by increased SDI in the bilateral somatosensory cortex, while decreased SDI was observed in the bilateral visual, prefrontal, and parietal cortices, as well as the left orbitofrontal cortex and temporal pole. Moreover, SDI alterations showed negative correlations with neurotransmitters, including 5-HT1a, 5-HT2a, D1, GABAa, SERT, and mGluR5. The SDI alteration-related genes were enriched in kinase binding. After 10-fold cross-validation, the SVM exhibited a mean accuracy of 0.767 (area under the curve = 0.972). Our research employed multimodal data to investigate hierarchical brain dysfunction in MDD and established its associations with neurotransmitters and transcriptome profiles. This approach may improve the understanding of the neural, biological, and molecular genetic underpinning of SDI in MDD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.